Lycopene, tomatoes, and the prevention of coronary heart disease

Experimental Biology and Medicine

Volumn 227, Issue 10, 2002, Pages 908-913

  Rao, A V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antioxidants; Carotenoids; Coronary heart disease; Lycopene; Oxidative stress

Indexed keywords

ANTIOXIDANT; BETA CAROTENE; CAROTENOID; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LYCOPENE; OLEORESIN; REACTIVE OXYGEN METABOLITE; RESIN; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD INTAKE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MACROPHAGE; MORTALITY; OXIDATIVE STRESS; PATHOGENESIS; PROPHYLAXIS; PROTEIN DEGRADATION; RISK FACTOR; TOMATO;

LYCOPERSICON ESCULENTUM;

EID: 0036845525     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222701011     Document Type: Conference Paper

References (41)

1. Rao AV, Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review. Autr Res 19:305-323, 1999.
2. Ames BN, Gold LS, Willet WC. Causes and prevention of cancer. Proc Natl Acad Sci U S A 92:5258-5265, 1995.
3. Pincemail J. Free radicals and antioxidants in human disease. In: Favier AE, Cadet J, Kalyanaraman B, Fontecave M, Pierre J-L, Eds. Analysis of Free Radials in Biological Systems. Basel: Birkhäuser Verlag, pp83-95, 1995.
4. Stadtman ER. Protein oxidation and aging. Science 257:1220-1224, 1992.
5. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 344:793-795, 1994.
6. Ames BN, Shigenaga MK, Hagan TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90:7915-7922, 1993.
7. Halliwell B, Murcia MA, Chirico S, Aruoma OI. Free radicals and antioxidants in food and in vivo: What they do and how they work. Crit Rev Food Sci Nutr 35:7-20, 1995.
8. Halliwell B. Free radicals, antioxidants and human disease: Curiosity, cause or consequence? Lancet 344:721-724, 1994.
9. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in pathogenesis of atherosclerosis. Annu Rev Med 43:219-225. 1992.
10. Heller FR, Descamps O, Hondekijn JC. LDL oxidation: Therapeutic perspectives. Atherosclerosis 137:S25-S31, 1998.
11. Parthasarathy S. Mechanisms by which dietary antioxidants may prevent cardiovascular diseases. J Med Food 1:45-51, 1998.
12. Morris DL, Kritchevsky, Davis CE. Serum carotenoids and coronary heart disease: The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. J Am Med Assoc 272:1439-1441. 1994.
13. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 9:1551-1558. 1995.
14. DiMascio P, Kaiser S, Sies H. Lycopene as the most effective biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274:532-538, 1989.
15. Steinbrecher UP. Zhang HF, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 9:166-168, 1990.
16. Witztum JL. Role of oxidized low density lipoprotein in atherogenesis. Br Heart J 69:S12-S18, 1993.
17. Kohlmeier L, Kark JD, Gomez-Garcia E, Martin BC, Steck SE, Kardinaal AFM, Ringstad J, Thamm M, Masaev V, Riemersma R, Martin-Moreno JM, Huttunen JK, Kok F. Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 146:618-626, 1997.
18. Agarwal S, Rao AV. Carotenoids and chronic diseases. Drug Metab Drug Interact 17:189-209, 2000.
19. Frei B. Cardiovascular disease and nutrient antioxidants: Role of low-density lipoprotein oxidation. Crit Rev Food Sci Nutr 351:83-98, 1995.
20. Gaziano J, Michael C, Hennekens H. The role of β-carotene in the prevention of cardiovascular disease. Ann N Y Acad Sci 691:148-155, 1993.
21. Holvoet P, Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEBJ 8:1279-1284, 1994.
22. Zock P, Katan MB. Diet, LDL oxidation, and coronary artery disease. Am J Clin Nutr 68:759-760, 1998.
23. Virtamo J. Rapola JM, Ripatti S, Heinonen OP. Taylor PR, Albanrs D, Huttunen OP. Effect of vitamin E and β-carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 158:668-675, 1998.
24. Stephens NG, Parsons A, Schodiel PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786, 1996.
25. Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevnian A, Johnson R, Azen SP. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atheroscloresis. J Am Med Assoc 273:1849-1854, 1995.
26. Arab L, Steck S. Lycopene and cardiovascular disease. Am J Clin Nutr 71(Suppl):1691S-1695S, 2000.
27. Kohlmeier L, Hastings SB. Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am J Clin Nutr 62(Suppl):1370S-1376S, 1995.
28. Rao AV, Agarwal S. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 19:563-569, 2000.
29. Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 163:739-744. 2000.
30. Dugas TR, Morel DW, Harrison EH. Impact of LDL carotenoid and α-tocopherol content on LDL oxidation by endothelial cells in culture. J Lipid Res 39:999-1007, 1998.
31. Fuhrman B, Elis A, Aviram M. Hypercholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophage. Biochem Biophys Res Commun 233:658-662, 1997.
32. Dugas TR. Morel DW, Harrison EH. Dietary supplementation with β-carotene, but not with lycopene inhibits endothelial cell-mediated oxidation of low-density lipoprotein. Free Radic Biol Med 26:1238-1244, 1999.
33. Diaz M, Frei B, Vita JA, Keany JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408-416, 1997.
34. Street DA, Comstock GW, Salkeld RM, Achuep W, Klag MJ. Serum antioxidant and myocardial infarction: Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation 90:1154-1161. 1994.
35. Gomez-Aracena J, Sloots J, Garcia-Rodriguez A. Antioxidants in adipose tissue and myocardial infarction in Mediterranean area. The EURAMIC study in Malaga. Nutr Metab Cardiovasc Dis 7:376-382, 1997.
36. Iribarren C, Folsom AR, Jacobs DR, Cross MD, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and sutoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 17:1171-1177, 1997.
37. Kritenson M, Zieden B, Kucinskiene Z, Elinder LS, Bergdahl B, Elwing B, Abaravicius A, Razinkoviene L, Calkauskas H, Olson A. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross sectional study of men aged 50. Br Med J 314:629-633, 1997.
38. Schmidt R, Fazekas F, Hayn M, Schmidt H, Kapeller P, Toob G, Offenbacher H, Schumacher M. Eber B, Weinrauch V, Kostner GM, Esterbauer H. Risk factors for microangiopathy-related cerebral damage in Aistrian stroke prevention study. J Neurol Sci 152:15-21, 1997.
39. Rao AV, Agarwal S. Effect of diet and smoking on serum lycopene and lipid peroxidation. Nutr Res 18:713-721, 1998.
40. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Canc 31:199-203, 1998.
41. Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study. Lipids 33:981-984, 1988.